Literature DB >> 9536332

Clinical and pathogenic factors in dialysis-related amyloidosis: current research findings.

F Gejyo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9536332     DOI： 10.1007/bf03194372

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  24 in total

1.  Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column.

Authors:  K Ohashi; M Hara; R Kawai; Y Ogura; K Honda; H Nihei; N Mimura
Journal:  Kidney Int       Date:  1992-06       Impact factor: 10.612

2.  [Hemodialysis: carpal tunnel syndrome and amyloid substance].

Authors:  H Assenat; E Calemard; B Charra; G Laurent; J C Terrat; T Vanel
Journal:  Nouv Presse Med       Date:  1980-05-31

Review 3.  Amyloidosis and its relationship to different dialysers.

Authors:  C van Ypersele de Strihou; J Floege; M Jadoul; K M Koch
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

4.  Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis.

Authors:  N Homma; F Gejyo; M Isemura; M Arakawa
Journal:  Nephron       Date:  1989       Impact factor: 2.847

5.  Purification and complete amino acid sequence of novel beta 2-microglobulin.

Authors:  H Odani; R Oyama; K Titani; H Ogawa; A Saito
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

6.  Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products.

Authors:  T Miyata; Y Iida; Y Ueda; T Shinzato; H Seo; V M Monnier; K Maeda; Y Wada
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

7.  Proteoglycans in haemodialysis-related amyloidosis.

Authors:  K Ohashi; M Hara; M Yanagishita; R Kawai; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits.

Authors:  J M Campistol; T Shirahama; C R Abraham; O G Rodgers; M Solé; A S Cohen; M Skinner
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

9.  Cystic radiolucencies of carpal bones, distal radius and ulna as a marker for dialysis-associated amyloid osteoarthropathy.

Authors:  N Homma; F Gejyo; H Kobayashi; H Saito; S Sakai; M Suzuki; Y Hirasawa; M Arakawa
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.

Authors:  T Miyata; O Oda; R Inagi; Y Iida; N Araki; N Yamada; S Horiuchi; N Taniguchi; K Maeda; T Kinoshita
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808
View more
  1 in total

1.  Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.